Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipoprotein (a) and stroke.

H J Milionis1, A F Winder, D P Mikhailidis

  • 1Department of Molecular Pathology and Clinical Biochemistry, Royal Free and University College Medical School, University College, London, UK.

Journal of Clinical Pathology
|August 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.

Lipids·2008
Same author

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study.

Expert opinion on pharmacotherapy·2008
Same author

Proceedings of the 23rd International Congress of Cardiology organized by the Hellenic Heart Foundation: May 1-3, 2008 Athens, Greece.

Angiology·2008
Same author

Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.

Expert opinion on pharmacotherapy·2008
Same author

Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes.

Expert opinion on pharmacotherapy·2008
Same author

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia.

Current medical research and opinion·2008
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026
Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026
Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026
Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026
See all related articles

Lipoprotein (a) (Lp(a)) may predict ischemic stroke risk, but studies show conflicting results. This review explores Lp(a) mechanisms in stroke and potential therapies.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Genetics

Background:

  • Strokes are a leading cause of death and disability.
  • Lipoprotein (a) (Lp(a)) is linked to vascular diseases like coronary artery disease.
  • The association between Lp(a) and ischemic stroke is debated due to conflicting study findings.

Purpose of the Study:

  • To review Lp(a)-related mechanisms in ischemic stroke pathogenesis.
  • To discuss Lp(a) associations with other cardiovascular risk factors.
  • To consider therapeutic strategies for lowering Lp(a) and stroke risk.

Main Methods:

  • Literature review of cross-sectional and prospective studies.
  • Analysis of Lp(a) related mechanisms in stroke.
  • Discussion of confounding factors in existing research.

Related Experiment Videos

Main Results:

  • Contradictory findings exist regarding Lp(a) as an ischemic stroke predictor.
  • Factors like sample size, ethnicity, and statistical methods may explain discrepancies.
  • Lp(a) mechanisms in stroke pathogenesis require further elucidation.

Conclusions:

  • Understanding Lp(a)'s role in ischemic stroke is crucial.
  • Further research is needed to clarify Lp(a) and stroke risk.
  • Therapeutic lowering of Lp(a) may reduce stroke incidence.